•
Jun 30, 2017

Corcept Therapeutics Q2 2017 Earnings Report

Total Revenue
$35.6M
Previous year: $19.7M
+80.3%
EPS
$0.13
Previous year: $0.03
+333.3%
Gross Profit
$34.8M
Previous year: $19.3M
+80.2%
Cash and Equivalents
$33.6M
Previous year: $41.8M
-19.5%
Free Cash Flow
$24.9M
Total Assets
$86.5M
Previous year: $56.8M
+52.3%

Corcept Therapeutics

Corcept Therapeutics